Company intelligence / Profile preview

Dib UltraNav Medical

El Paso, Texas, United States

Ownership: Private
Development stage: Other

Overview

Dib UltraNav Medical has successfully commercialized the Dib UltraNav Transseptal Catheter System, which received FDA 510(k) clearance in March 2022. As of 2023, the device has been successfully used in 23 human cases at major cardiology centers in Arizona and Minnesota. The system has demonstrated improved safety and accuracy in transseptal procedures, with the ability to eliminate the need for general anesthesia and overnight hospital stays in certain procedures.

Industry: Surgical Medical Devices

Partnerships

Franklin Mountain Medical (lead investor and subsidiary relationship)

Beyond the preview

Go deeper on Dib UltraNav Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dib UltraNav Medical.

Explore the full profile